SN

Sangeeta N. Bhatia

MIT Professor, Entrepreneur, Diversity advocate

Cambridge, Massachusetts

Investor
VC

Invests in

Stages:

Series A
Seed

  • Min Investment:

    $100,000.00

  • Max Investment:

    $5,000,000.00

  • Target Investment:

    $1,500,000.00

Education

Lists including Sangeeta

AP
AO
AS
AN

Based in UK

1884 people

AM
AR
AB
AF

Based in Boston & Cambridge

668 people

AT
AS
AT
AH

All Series A Investors

14752 people

AM
AT
AS
AR

All Seed Investors

19695 people

Work Experience

MI
Massachusetts Institute of Technology

2005

  • Professor, Director Marble Center for Cancer Nanomedicine

    2005

RT
Ropirio Therapeutics, Inc.

2023

  • Co-Founder

    2023

MB
Matrisome Bio

2023

  • Co-Founder

    2023

PT
Port Therapeutics

2022

  • Co-Founder

    2022

SB
Satellite Bio

2020

  • Co-Founder

    2020

GB
Glympse Bio

2015

  • Co-Founder

    2015

BU
Brown University

2015

  • Fellow, Board of Trustees

    2015

VP
Vertex Pharmaceuticals

2015

  • Member Board of Directors

    2015

B
BioIVT

2008 - 2018

  • Co-Founder, Hepregen

    2008 - 2018

NC
National Cancer Institute (NCI)

2013 - 2017

  • Member, Board of Scientific Advisors

    2013 - 2017